BACKGROUND Globally,Liver cirrhosis is the 14th leading cause of death and poses a significant threat to human health.AIM To investigate the effects of a multidisciplinary collaboration model on postoperative recovery...
Supported by the National Natural Science Foundation of China,No.81874390 and No.81573948;Shanghai Natural Science Foundation,No.21ZR1464100;Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission,No.22S11901700;the Shanghai Key Specialty of Traditional Chinese Clinical Medicine,No.shslczdzk01201.
BACKGROUND Esophageal and gastric variceal bleeding is a catastrophic complication of portal hypertension,most commonly caused by cirrhosis of various etiologies.Although a considerable body of research has been condu...
The management of portal hypertension and its complications,such as variceal bleeding,in patients with cirrhosis often involves the use of nonselective betablockers(NSBBs)and a transjugular intrahepatic portosystemic ...
BACKGROUND Severe symptoms associated with sepsis syndrome(SS)are considered a severe threat,which not only increases therapeutic difficulty but also causes a prognostic mortality rate.However,at present,few related s...
National Natural Science Foundation of China,No.82273484;Project of Chongqing Young and Middle-aged Medical Talents.
BACKGROUND The transjugular intrahepatic portosystemic shunt(TIPS)is an important technique for treating complications related to portal hypertension in patients with cirrhosis,and the number of publications in the TI...
BACKGROUND Cirrhosis is a common liver disease,and ascites is one of the common clinical conditions.However,the clinical manifestations of ascites combined with hyponatremia as a high-risk condition and its relationsh...
Supported by National Natural Science Foundations of China,No.82174160;and Anhui Natural Science Foundation,No.2008085QH389。
BACKGROUND Partial splenic embolization(PSE)has been suggested as an alternative to splenectomy in the treatment of hypersplenism.However,some patients may experience recurrence of hypersplenism after PSE and require ...
BACKGROUND Esophageal-gastric variceal bleeding(EGVB)represents a severe complication among patients with cirrhosis and often culminates in fatal outcomes.Interven-tional therapy,a rapidly developing treatment modalit...
BACKGROUND Individuals with refractory ascites in the context of liver cirrhosis typically face an adverse prognosis.The transjugular intrahepatic portosystemic shunt(TIPS)is an efficacious intervention,but there is a...
BACKGROUND To avoid acute variceal bleeding in cirrhosis,current guidelines recommend screening for high-risk esophageal varices(EVs)by determining variceal size and identifying red wale markings.However,visual measur...